KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases

NCT06451757 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Mitochondrial Diseases
Maternally Inherited Diabetes and Deafness (MIDD)
Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS)
Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation

Interventions

DRUG: Sonlicromanol
DRUG: Placebo

Sponsor

Khondrion BV